Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sagent Pharm Inc (SGNT)

Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sagent Pharm Inc 1901 NORTH ROSELLE ROAD SUITE 700 SCHAUMBURG IL 60195

www.sagentpharma.com P: 847-908-1600

Description:

Sagent Pharmaceuticals, Inc. is a pharmaceutical company that develops and sources products with primary focus on generic injectable pharmaceuticals. Products offered by the Company cover a range of anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled, ready-to-use syringes, medical devices and premix bags. Sagent Pharmaceuticals, Inc. is is based in Schaumburg, Illinois.

Key Statistics

Overview:

Market Capitalization, $K 715,130
Shares Outstanding, K 33,090
Annual Sales, $ 318,300 K
Annual Net Income, $ -21,880 K
Last Quarter Sales, $ 71,720 K
Last Quarter Net Income, $ -520 K
60-Month Beta 1.65
% of Insider Shareholders 30.10%
% of Institutional Shareholders 99.71%

Growth:

1-Year Return 8.58%
3-Year Return -7.95%
5-Year Return 6.72%
5-Year Revenue Growth 329.84%
5-Year Earnings Growth -103.59%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.02 on 05/03/16
Next Earnings Date 08/16/16
Earnings Per Share ttm 0.41
EPS Growth vs. Prev Qtr -94.74%
EPS Growth vs. Prev Year -50.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SGNT Ratios

Ratio
Price/Earnings ttm 53.00
Price/Earnings forward 79.02
Price/Earnings to Growth 2.26
Return-on-Equity % 4.99%
Return-on-Assets % 3.64%
Profit Margin % -6.87%
Debt/Equity 0.01
Price/Sales 2.25
Price/Cash Flow 25.41
Price/Book 2.83
Book Value/Share 7.67
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar